Literature DB >> 21586496

Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?

Joachim Voss1, Young Ah Goo, Kevin Cain, Nancy Woods, Monica Jarrett, Lynne Smith, Robert Shulman, Margaret Heitkemper.   

Abstract

Recently, biobehavioral nursing scientists have focused their attention on the search for biomarkers or biological signatures to identify patients at risk for various health problems and poor disease outcomes. In response to the national impetus for biomarker discovery, the measurement of biological fluids and tissues has become increasingly sophisticated. Urine proteomics, in particular, may hold great promise for biobehavioral focused nursing scientists for examination of symptom-and syndrome-related research questions. Urine proteins are easily accessible secreted proteins that provide direct and indirect windows into bodily functions. Advances in proteomics and biomarker discovery provide new opportunities to conduct research studies with banked and fresh urine to benefit diagnosis, prognosis, and evaluation of outcomes in various disease populations. This article provides a review of proteomics and a rationale for utilizing urine proteomics in biobehavioral research. It addresses as well some of the challenges involved in data collection and sample preparation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586496      PMCID: PMC3569484          DOI: 10.1177/1099800411402056

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  59 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 2.  Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer.

Authors:  Wei Chua; Melissa M Moore; Kellie A Charles; Stephen J Clarke
Journal:  Curr Opin Mol Ther       Date:  2009-12

3.  Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome.

Authors:  Ying Ding; Bin Lu; Dongbo Chen; Lina Meng; Yan Shen; Shuo Chen
Journal:  Proteomics       Date:  2010-07       Impact factor: 3.984

Review 4.  Proteomic assays for the detection of urothelial cancer.

Authors:  Kris E Gaston; H Barton Grossman
Journal:  Methods Mol Biol       Date:  2010

Review 5.  Screening and detection of ovarian cancer.

Authors:  Ginger Breedlove; Cara Busenhart
Journal:  J Midwifery Womens Health       Date:  2005 Jan-Feb       Impact factor: 2.388

6.  Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.

Authors:  Kelly A Metcalfe; Aletta Poll; Robert Royer; Marcia Llacuachaqui; Anna Tulman; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

7.  Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.

Authors:  Irina A Buhimschi; Guomao Zhao; Edmund F Funai; Nathan Harris; Isaac E Sasson; Ira M Bernstein; George R Saade; Catalin S Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2008-11       Impact factor: 8.661

8.  Urinary proteomic biomarkers in coronary artery disease.

Authors:  Lukas U Zimmerli; Eric Schiffer; Petra Zürbig; David M Good; Markus Kellmann; Laetitia Mouls; Andrew R Pitt; Joshua J Coon; Roland E Schmieder; Karlheinz H Peter; Harald Mischak; Walter Kolch; Christian Delles; Anna F Dominiczak
Journal:  Mol Cell Proteomics       Date:  2007-10-19       Impact factor: 5.911

9.  Mass spectrometric characterization of gelsolin isoforms.

Authors:  G Pottiez; N Haverland; P Ciborowski
Journal:  Rapid Commun Mass Spectrom       Date:  2010-09-15       Impact factor: 2.419

10.  Autonomic nervous system function during sleep among women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert L Burr; Kevin C Cain; James D Rothermel; Carol A Landis; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more
  5 in total

1.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

2.  Use of captive spray ionization to increase throughput of the data-independent acquisition technique PAcIFIC.

Authors:  John D Chapman; J Scott Edgar; David R Goodlett; Young Ah Goo
Journal:  Rapid Commun Mass Spectrom       Date:  2016-05-15       Impact factor: 2.419

3.  Stress and gene expression of individuals with chronic abdominal pain.

Authors:  Ralph Michael Peace; Benjamin L Majors; Nayan S Patel; Dan Wang; Arseima Y Del Valle-Pinero; Angela C Martino; Wendy A Henderson
Journal:  Biol Res Nurs       Date:  2012-10       Impact factor: 2.522

Review 4.  Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers.

Authors:  Ivana Plavšić; Goran Hauser; Mladenka Tkalčić; Sanda Pletikosić; Nermin Salkić
Journal:  Gastroenterol Res Pract       Date:  2015-06-11       Impact factor: 2.260

5.  Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.

Authors:  Kristen R Weaver; Gail D' Eramo Melkus; Jason Fletcher; Wendy A Henderson
Journal:  Nurs Res       Date:  2018 May/Jun       Impact factor: 2.381

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.